Pretreatment Cancer-Related Cognitive Impairment in Hodgkin Lymphoma Patients
Background: Cancer-related cognitive impairment (CRCI) is one of the most serious side effects of cancer that negatively impacts the quality of life of cancer patients and survivors. There is evidence of CRCI in Hodgkin lymphoma patients (HL); however, there is a lack of studies examining the presen...
Main Authors: | Veronika Juríčková, Dan Fayette, Juraj Jonáš, Iveta Fajnerová, Tomáš Kozák, Jiří Horáček |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/10/652 |
Similar Items
-
Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01) -
Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01) -
The Treatment of Non-Hodgkin's Lymphomas
by: David J. Straus
Published: (2023-08-01) -
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
by: Sylvia Hartmann, et al.
Published: (2021-10-01) -
Surgery for non-Hodgkin’s lymphoma
by: Elroy Patrick Weledji, et al.
Published: (2015-07-01)